Deborah Schmiel

Title: **Deborah Schmiel: Innovator in Meningococcal Vaccine Development**

Introduction

Deborah Schmiel, based in Rockville, MD, is a trailblazing inventor with significant contributions to medical research. She is best known for her innovative work in developing a vaccine aimed at combating meningococcal disease, particularly the subtype B strain. Her dedication to public health and advancement in vaccine technology has set her apart in the field of immunology.

Latest Patents

Deborah holds a patent for the "Meningococcal multivalent native outer membrane vesicle vaccine, methods of making and use thereof." This groundbreaking technology offers vaccine compositions comprising native outer membrane vesicles (NOMVs) derived from genetically modified strains, which provide protective immunity to meningococcal disease. The patent outlines effective methods for immunizing both animals and humans against this serious health threat by administering the innovative vaccine composition.

Career Highlights

Deborah is currently employed at the U.S. Army Medical Research and Materiel Command, where she continues to expand her research in vaccine development. Her efforts are crucial in addressing global health challenges and improving immunization strategies for meningococcal disease.

Collaborations

Throughout her career, Deborah has collaborated with esteemed colleagues, including Wendell David Zollinger and Mikhail Donets. These partnerships have fostered a robust research environment, leading to advancements in vaccine technology and ensuring comprehensive approaches to public health issues.

Conclusion

Deborah Schmiel’s innovative spirit and dedication to advancing vaccine research exemplify the critical role of inventors in modern medicine. With her patented vaccine technology, she is making significant strides in the fight against meningococcal disease, ultimately contributing to the health and safety of communities worldwide.